Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer

— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...
September 12, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer

– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage development – SAN MATEO, Calif., Sept. 12, 2023 (GLOBE...
August 24, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors

– Board of Director appointments follow the Company’s recent launch and $200 million Series A financing in March 2023 – – Appointments include industry veterans John Orwin as Chairman, David Lubner...
May 31, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics to Present at the Jefferies Global Healthcare Conference

SAN MATEO, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CARGO), a biotechnology company advancing a next generation of CAR T-cell therapies for cancer, today announced that...
March 01, 2023 09:30 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Raises $200 Million in Oversubscribed, Upsized Series A Financing to Advance its Pipeline of Next Generation CAR T-Cell Therapies

– Series A financing co-led by Third Rock Ventures, RTW and Perceptive Xontogeny Venture Fund, and includes new investors Nextech, Janus Henderson Investors, Ally Bridge Group, Wellington Management,...

keyboard_arrow_left Previous Page